Description
This project builds capabilities for therapeutic antibody development, fortifies early-phase clinical research infrastructure, advances biotech IP for the health and economic benefit of Canadians and enables rapid response to future pandemi…
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02022-03-18$225,000,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2022-03-18(start date) | $225,000,000 | — | This project builds capabilities for therapeutic antibody development, fortifies early-phase clinical research… |
Related records · 9
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 838509446)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 172-2022-2023-Q4-1002444 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $6,325,000 | FY2023 |
| 033-2020-2021-Q1-512889 | Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream 2 - Growth | $175,631,000 | FY2021 |
| GC-WD-DEO-2019-2020-Q2-114 | Western Economic Diversification Canada | Diversification de l'économie de l'Ouest Canada · Regional Economic Growth through Innovation | $5,000,000 | FY2020 |
| 172-2018-2019-Q4-921989 | National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms | $2,617,300 | FY2019 |
Other recipients funded under "SIF Stream3- Attraction" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q4-820215 | IBM Canada Limited - IBM Canada Ltée | FY2025 | $210,000,000 | FY2025 |
| 033-2024-2025-Q3-514896 | Dow Chemical Canada ULC | FY2025 | $400,000,000 | FY2025 |
| 033-2024-2025-Q1-820057 | Aspect Biosystems Ltd. | FY2025 | $49,000,000 | FY2025 |
| 033-2024-2025-Q3-819849 | Ericsson Canada Inc. | FY2025 | $79,100,000 | FY2025 |
| 033-2024-2025-Q1-820155 | Heidelberg Materials Canada Limited | FY2025 | $49,000,000 | FY2025 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2023-2024-Q1-819720 · retrieved 2026-11-14.